Atara reports higher net loss in fourth quarter
Thousand Oaks-based Atara Biotherapeutics reported financial results for the fourth quarter and full year 2023 along with recent business highlights and key upcoming milestones for 2024 on March 28. Atara reported a net loss of $60.5 million or 56 cents per share in the fourth quarter of 2023 along with a net loss of $276.1 million Read More →
Acelyrin reports higher net loss in 2023 as company prepares for breakthrough
Conejo Valley-based Acelyrin, a clinical, pre-revenue biotechnology company, reported its financial results for the full year 2023 on March 28. According to the March 28 report, the company’s net loss for the full year ended Dec. 31 was $381.6 million, compared to $64.8 million for 2022. The company primarily saw expenses increase in research and Read More →
Analysts remain all-in on Deckers stock as shares near $1K
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Portfolio watch
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Blois Construction co-founder, political activist Jean Blois dies at 96
Jean Williamson Blois, one of the leading women in business and politics on the South Coast, died March 22 at age 96. Blois was a co-founder of the political movement that led to the successful effort to incorporate the City of Goleta. She served on its first city council and was instrumental in guiding Goleta Read More →
Embracing digital options: Small businesses access to capital continues growing
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Portfolio watch
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
